Is CYP1A2 useful for skin aging?

Based on the provided context, there is no direct evidence addressing whether CYP1A2 is useful for skin aging. CYP1A2 is primarily known for metabolizing caffeine and certain drugs. Some mechanistic studies suggest it may influence oxidative stress or detoxification pathways that could theoretically affect skin aging, but robust human trials linking specific CYP1A2 variants to skin aging outcomes (e.g., wrinkles, elasticity) are lacking. Consumer DNA tests like those from MyBody-X may market such associations, but the evidence remains weak and largely speculative. Effect sizes are small, and lifestyle factors (diet, UV exposure) dominate skin aging. Therefore, relying on CYP1A2 genotyping for skin aging guidance is not evidence-based. The evidence grade is 'unclear' due to insufficient context and lack of validated clinical utility.